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Abstract
Stem cell therapies for neurodegenerative disorders require accurate delivery of the transplanted cells to the sites of
damage. Numerous studies have established that fluid injections to the hippocampus can induce lesions in the dentate
gyrus (DG) that lead to cell death within the upper blade. Using a mouse model of temporal lobe epilepsy, we previously
observed that embryonic stem cell-derived neural progenitors (ESNPs) survive and differentiate within the granule cell layer
after stereotaxic delivery to the DG, replacing the endogenous cells of the upper blade. To investigate the mechanisms for
ESNP migration and repair in the DG, we examined the role of the chemokine CXCL12 in mice subjected to kainic acid-
induced seizures. We now show that ESNPs transplanted into the DG show extensive migration through the upper blade,
along the septotemporal axis of the hippocampus. Seizures upregulate CXCL12 and infusion of the CXCR4 antagonist
AMD3100 by osmotic minipump attenuated ESNP migration. We also demonstrate that seizures promote the differentiation
of transplanted ESNPs toward neuronal rather than astrocyte fates. These findings suggest that ESNPs transplanted into the
adult rodent hippocampus migrate in response to cytokine-mediated signals.
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Introduction
Stem cell-based treatments for neurodegenerative diseases and
central nervous system (CNS) injuries are currently in the pipeline.
Embryonic stem cell (ESC)-derived neural progenitors (ESNPs)
are among the most promising candidate neural cell types under
investigation for CNS repair because they retain the potential to
proliferate and differentiate into multiple neuronal and glial
subtypes following transplantation [1], with the specific outcome
dependent upon local environmental cues [2,3]. As these cells
differentiate, they form functional neurons capable of incorporat-
ing into the host brain [4].
For effective CNS repair, ESNPs must be directed to sites of
damage [5,6], but little is known about how these cells migrate
after transplantation. Effective therapies for widespread white
matter damage in diseases like multiple sclerosis may require long-
range dispersal of glial progenitors [7,8]. In contrast, conditions
such as spinal cord injury, Alzheimer’s disease, Parkinson’s disease,
stroke, or temporal lobe epilepsy (TLE), may need focal delivery of
replacement cells to denervated sites [9]. Therefore, a better
understanding of the molecular mechanisms involved in migration
and differentiation of ESNPs and their derivatives is essential for
successful stem cell-based CNS therapy design.
A number of studies have shown that neural stem cells (NSCs)
derived from either the adult CNS or ESCs incorporate into the
upper blade of the dentate gyrus (DG) granule cell layer (GCL)
and differentiate into dentate granule neurons (DGNs) after
transplantation into the adult hippocampus [10]. Previous analysis
suggests that transplanted cells disperse passively throughout the
site of a neurodegenerative lesion caused by fluid injections into
the upper blade of the DG [11,12]. Whether transplanted NSCs
actively migrate in this region has not been well studied. We
therefore examined the distribution of transplanted ESNPs after
they were deposited in the adult hippocampus in mice that had
been subjected to kainic acid (KA)-induced status epilepticus (SE).
Seizures may influence migration and/or differentiation through
upregulation of stromal derived factor-1a (CXCL12 or SDF-1a), a
potent chemokine produced by the meninges and DGNs both
during embryogenesis and in the adult hippocampus [13,14].
CXCL12 signaling via its primary receptor, CXCR4, guides
migrating granule neural precursors from the hilus into the DG
during development [15,16]. CXCL12 also acts as a chemoat-
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the developing cerebral cortex and hippocampus [17]. In addition,
new evidence suggests that CXCL12 is critical for the migration of
NSCs from the subventricular zone (SVZ) into the rostral
migratory stream (RMS) [18], as well as the migration and
proliferation of NSCs engrafted into the spinal cord in a rodent
model of multiple sclerosis [19]. Moreover, CXCL12 regulates the
migration of both endogenous and transplanted NSCs in stroke
models in adult rodents [20,21]. This chemokine pathway also
influences the differentiation of newborn DGNs in the adult
hippocampus [22,23].
We examined the extent and direction of migration of ESNPs
transplanted to the adult DG and observed significant movement
from the injection sites posteriorly along the upper blade of the
DG into sites where the endogenous DGNs degenerate. Expres-
sion of CXCR4 by ESNPs suggests that CXCL12 is involved in
this process. This hypothesis was supported by our finding that
seizures upregulated CXCL12 expression in the hippocampus
DG. Moreover, ESNPs showed a chemotactic response to
CXCL12, both in vitro and in vivo. These data suggest that a
localized source of CXCL12 may direct the migration of ESNPs
towards specific regions of neurodegeneration in the adult
hippocampus.
A second goal was to examine whether SE prior to
transplantation influenced migration or differentiation of trans-
planted ESNPs. Seizures have a profound influence on gene
expression, synaptic connectivity, and neuronal survival in the
hippocampus [24,25]. Patients with severe chronic TLE show
distinctive neuropathological changes including hippocampal
sclerosis and cell death throughout Ammon’s horn and the
dentate hilar region [26,27]. Similar patterns of neuronal loss are
apparent following SE in experimental models [28,29]. Seizures
also induce abnormal upregulation of neurogenesis in the
subgranular zone (SGZ) of the human and rodent DG
[30,31,32,33] and alter the fates of endogenous NSCs [34]. Our
results demonstrate that seizures induce a marked change in the
differentiation of ESNPs into neurons rather than astrocytes.
Materials and Methods
Cell Culture
YC5 mouse ESC cultures were maintained on a feeder layer of
STO fibroblasts, with DMEM (Sigma, St. Louis, MO) supple-
mented with leukemia inhibitory factor (LIF), 1-thioglycerol and
Knockout Serum Replacement (Gibco, Grand Island, NY). Neural
progenitors were derived using a modification of a previous
protocol [35]. ESCs were differentiated into embryoid bodies in
suspension culture in the presence of fetal bovine serum (Atlanta
Biologicals, Lawrenceville, GA) and the absence of LIF, then
grown in adherent culture using serum-free medium supplemented
with insulin, transferrin, selenium (ITS, Gibco), and fibronectin
(Sigma). ESNPs were expanded in neural expansion media
(DMEM/F12 [Sigma], putrescine [Sigma] and laminin [Sigma]),
containing fibroblast growth factor 2 (FGF2, Sigma) and
epidermal growth factor (EGF, Sigma) for 5–9 days. For in vitro
assays and ESNP characterization, cultures of ESNPs were grown
in Permanox chamber slides (Thermo Scientific, Rochester, NY).
Cells were fixed in 3.7% formaldehyde in 0.1 M phosphate buffer
and stained by immunocytochemistry for cell type-specific markers
and nuclear staining with Hoechst 33342 (Invitrogen, La Jolla,
CA). To test the effects of CXCL12 (Peprotech, Rocky Hill, NJ) or
AMD3100 (Sigma), ESNPs grown on Permanox were treated with
200 ng/mL CXCL12 and/or 5 mg/mL AMD3100 for three days
with media changes each day.
Surgical Procedures
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Wesleyan University Animal Care
and Use Committee (Protocol Number: 090093). Eight- to ten-
week-old male B6.CB17-Prkdc scid/SzJ mice (Jackson Laborato-
ries) were injected subcutaneously with KA (Sigma, 22.5 mg/kg in
saline) to induce SE. Control mice received injections of PBS.
Seizures were graded as described elsewhere and attenuated by
sodium pentobarbital (50 mg/kg, i.p., Abbott, North Chicago, IL),
10 min after reaching stage 5 seizures, as described previously
[28,36]. Cell death in the hippocampus from single systemic
injections of KA in this mouse line has been previously described
[2].
ESNPs were transplanted into the DG by means of stereotaxic
surgery, 7 days following the induction of seizures by the
chemoconvulsant KA. Surgical levels of anesthesia were induced
by inhalation of isoflurane (Sigma). The stereotaxic surgery was
performed in a rodent stereotaxic frame fitted with an isoflurane
gas mask adaptor for mice (Kopf, Tujunga, CA). Coordinates for
stereotaxic injections into the hippocampus were based on distance
from Bregma; 22.0 mm posterior, 21.95 mm lateral, and
21.9 mm ventral to the pial surface. Approximately 50,000 cells
in 1 ml of neural expansion media were injected over a period of
10 min. The needle was then removed and the incision sealed with
veterinary-grade tissue adhesive (Vetbond, 3 M). To test migra-
tion, osmotic minipumps (Alzet Model 1004, Cupertino, CA) were
placed subcutaneously in the intrascapular area one day prior to,
or 3 hours following, transplantation. Osmotic minipumps were
filled with either 0.1 M phosphate buffer or 50 mg/mL AMD3100
diluted in 0.1 M phosphate buffer. The incision was sealed with
veterinary-grade tissue adhesive and wound clips.
Histological Analyses
Mice were euthanized with a lethal dose of sodium pentobar-
bital (Nembutal, Abbott Labs, North Chicago, IL) followed by
transcardial perfusion with a heparinized phosphate (PO4) buffer
solution containing 10% sucrose, then 4% PFA in 0.1 M PO4.
Brains were cryogenically protected using graded sucrose solutions
to 30% in 0.1 M PO4. Brains were then embedded in tissue
freezing medium (Triangle Biomedical Sciences, Durham, NC)
and frozen at 280uC. Cryostat sections were cut at 12-mm
intervals along the coronal plane and mounted onto Superfrost
Plus slides, briefly dried on a slide warmer, and then stored at
280uC until immunohistochemical analyses were performed.
Immunostaining
ESNPs were cultured in chamber slides, fixed in 3.7%
formaldehyde for 10 minutes at room temperature, rinsed in
PBS, and permeabilized in 0.1% Triton X-100/PBS for 10
minutes at room temperature. After a blocking step (2% bovine
serum albumin in 0.1% Triton X-100/PBS) for 1 hour at room
temperature, primary antibodies were placed in each chamber
overnight at 4uC. For all immunostaining experiments, a negative
control experiment was performed in which the primary antibody
was omitted. For immunohistochemistry, brain sections were
briefly rehydrated in PBS. After blocking (2% bovine serum
albumin, 10% normal goat serum in 0.1% Triton X-100/PBS) for
1 hour at room temperature, primary antibodies were applied in
blocking buffer and incubated overnight at 4uC. Antibodies were
diluted as follows: mouse anti-nestin, 1:1,000 (Chemicon,
Temecula, CA); mouse anti-TuJ-1, 1:1,000 (Covance); rabbit
anti-doublecortin, 1:1,000 (Sigma); mouse anti-Prox1, 1:200
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mouse anti-NeuN 1:500 (Chemicon); rabbit anti-CXCR4 1:200
(Torrey Pines, East Orange, NJ); rabbit anti-CXCL12 (Abcam,
Cambridge, MA). After rinsing, secondary antibodies were then
applied, diluted 1:1,000 (Alexa-Fluor 568- or 647-conjugated goat
anti-mouse IgG, Alexa-Fluor 568- or 647-conjugated goat anti-
rabbit IgG, Alexa-Fluor 568-conjugated goat anti-rat IgG;
Invitrogen, La Jolla, CA) in blocking buffer for 1 hour at room
temperature. Enhanced yellow fluorescent protein (EYFP)-positive
cells were visualized by using either rabbit anti-green fluorescent
protein (GFP) diluted 1:1,000 or mouse anti-GFP diluted 1:1,000
(Invitrogen), followed by Alexa-Fluor 488. Cell nuclei were then
labeled with Hoechst 33342 (Molecular Probes, Eugene, OR),
diluted 1:10,000, and sections were mounted in gelvatol.
In Vitro Migration Assay
The top surfaces of8 mm-pore transwells(Corning,Corning,NY)
were coated with 2 mg/mL laminin and ESNPs were seeded in
DMEM/F12 medium at a density of 150,000 cells per transwell.
Transwells were inserted into 24-well culture plates on top of
0.5 mL of DMEM/F12 containing varying concentrations of
CXCL12 recombinant peptide (Peprotech, Rocky Hill, NJ). In
order to block CXCR4 receptors, ESNPs were first incubated in
varying amounts of AMD3100 (Sigma) for 30 min. at room
temperature, washed in PBS and then resuspended in DMEM/
F12. The transwells were allowed to incubate for 18 hours at 37uC,
washed three times in PBS, fixed in 3.7% formaldehyde and stained
for nuclei with Hoechst. Transwell membranes were removed and
the underside of the membrane was imaged and nuclei counted
using NIS-Elements (Nikon, Melville, NY) software.
Quantitative and Semi-Quantitative PCR
Reverse transcription (RT) and PCR reactions were performed
as previously described [37]. Briefly, total RNA was extracted
from ESCs, ESNPs, E14.5 whole brain and whole adult
hippocampal lysates using Ultraspec-RNA (Biotecx Laboratories,
Inc., Houston, TX). RNA was treated with RNAse free DNase I
(Invitrogen) and reverse-transcribed with MMLV-RT (Invitrogen).
cDNAs were amplified with various primers using Taq-ReadyMix
(Sigma). b-actin was used as a loading control. Primer sequences
for semi-quantitative PCR were as follows, b-actin: 59-
GGCCCAGCGCAAGCGAGGTATCC -39 and 59- ACGCAC-
GATTTCCCTCTCAGC -39, CXCL12: 59- GCTAAGGT-
TTGCCAGCATAAAGAC -39 and 59- ACAGCGGTGAGA-
AGCGGAAGTCAG -39, CXCR4: 59- ACAGGTACATCTGT-
GACCGCCTTT -39 and 59- TGCTCTCGAAGTCACATC-
CTTGCT -39, and CXCR7: 59- CTGAGGTCACTTGGTC -39
and 59- GATGGAGAGATAGCGGTCCAC -39. Cycle number
for each primer pair was determined individually so that
amplification was in the exponential range and had not reached
a plateau.
Real-time RT-PCR was performed using 100 ng of total cDNA
per reaction. cDNA was combined with primer/probe sets for
CXCL12 and GAPDH and TaqMan Gold RT-PCR Master Mix
and run on an ABI 7300 (all Applied Biosystems, Foster City, CA).
The RT-PCR profile consisted of one cycle at 50uC for 2 min and
95uC for 10 min, followed by 40 cycles at 95uC for 15 s and 60uC
for 1 min. Results of the real-time RT-PCR were normalized to
GAPDH. To assess the difference in mRNA levels, the data were
analyzed using the 2-CT method.
Quantification of Graft Size and Migration
Transplant grafts were measured by sampling brain sections
every 120 mm through the hippocampus and the injection site.
Area measurements of the grafts were calculated using NIS-
Elements software (Nikon Instruments Inc., Melville, NY).
Volumetric calculations of the grafts were calculated from the
cross-sectional areas of the grafts multiplied by the distance
between sampled sections. Statistical analysis was performed using
Student’s T-test and ANOVA using Microsoft Excel. Significance
was determined as having a p value less than 0.05.
Results
ESNP Differentiation In Vitro
YC5 mESCs were differentiated into ESNPs using a modifica-
tion of a standard embryoid body-based protocol, using defined
media [35]. At the time of transplantation, over 90% of the cells
expressed the NSC marker nestin, and less than 10% expressed
the immature neuronal marker b-III tubulin (Fig. S1A–C). The
transplant population also expressed additional markers for neural
precursors (Sox1) as well as anterior (Otx1) and ventral forebrain
markers (Mash1, Nkx2.1) and dorsal markers (Pax7), demonstrat-
ing the presence of broad regional identities in these cultures
(Figure S1D).
Injection Site Location Influences ESNP Dispersion in the
Adult Hippocampus
Previously, we reported that ESNPs survive and differentiate
into neurons in the DG of mice, following KA-induced seizures
[2]. To examine whether dispersion of ESNPs is affected by the
site of injection, we compared graft location following injections
into different locations. When the stereotaxic injection sites were
located closer to CA3 (green arrows, Figure 1A), ESNPs tended to
settle in the hippocampal fissure (HF) immediately following
injection (Figure 1B), and remain there up to 4 weeks following
transplantation (Figure 1C). ESNPs transplanted to the HF
survived but did not migrate into the hippocampus from the
fissure (Figure 1C). When the needle track was close to, or pierced
the DG (blue arrows, Figure 1A), the ESNPs were mainly localized
within the infragranular zone beneath the upper blade of the DG
shortly after transplantation (Figure 1D). After 4 weeks however,
the transplanted cells had dispersed through the upper blade of the
DG (Figure 1E). To determine whether the dispersion was linked
to neurodegeneration within the granule cell layer of the DG, we
examined NeuN+ neurons in the GCL at different times after
injections were made. Over the course of a week following ESNP
transplantation, we observed a prominent loss of NeuN+ cells in
the GCL, particularly in the upper blade (Figure S2). The ESNPs
infiltrated the upper blade by 3 days after transplantation and by 4
weeks had filled in the sites in the GCL where endogenous DGNs
underwent degeneration (Figure S2). These results show that
transplanted ESNPs incorporate into lesions in the DG of the
hippocampus, in agreement with previous studies using fetal NSCs
[10].
Migration of ESNPs in the DG
We next asked whether transplanted ESNPs showed directional
migration within the DG. To address this question, we
reconstructed graft locations in the DG at different time points.
When cells were transplanted into the upper blade in the dorsal
hippocampus (asterisks, Figure 2A), ESNPs dispersed posteriorly
over the course of one week, along the septotemporal axis of the
hippocampus (Figure 2A). Cells in these grafts rarely migrated
away from the upper blade. Conversely, ESNPs transplanted into
other regions of the hippocampus were never observed to disperse
into the infragranular zone (data not shown). The ESNP grafts in
the upper blade reached a maximum septotemporal extent by 7
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28 days (Figure 2B). During this period, ESNPs became more
evenly distributed (Figure 2C). These observations, demonstrating
that ESNPs transplanted into the SGZ or hilus dispersed within
the infragranular zone, suggest that an active process mediated by
local signals within the DG may regulate ESNP migration.
ESNPs Migrate in Response to a Source of CXCL12
To determine whether ESNP dispersion is an active process
guided by established chemoattractants, we investigated the role of
CXCL12, a known chemokine expressed in the adult brain [38].
In culture, ESNPs, as well as ESC-derived immature neurons,
expressed CXCR4, a receptor for CXCL12 required for
CXCL12-mediated chemotaxis (Figure 3A, B). Moreover, trans-
well migration assays demonstrated clearly that ESNPs migrated
in a dose-dependent manner towards a source of CXCL12
(Figure 3C). These results suggest an active migration process that
is dependent upon CXCL12.
To further investigate CXCL12-mediated guidance mecha-
nisms, we next examined expression of CXCR4 and CXCR7, the
two receptors that bind CXCL12 [39]. YC5 ESCs and ESNPs
express mRNA for both the chemokine and its receptors
(Figure 3D). To determine whether CXCL12-induced migration
is mediated via CXCR4 receptors, we blocked CXCR4 receptors
with a small pharmacological inhibitor, AMD3100 [40]. This
inhibitor effectively reduced ESNP migration towards an in vitro
source of CXCL12 (Figure 3E). These data suggest that CXCL12-
mediated migration of ESNPs requires the function of CXCR4.
This result, however, could be due to altered proliferation or
differentiation of ESNPs, so we next determined whether
CXCL12 affects these properties. In vitro treatment with CXCL12
did not increase phospho-histone H3 levels or alter nestin or b-III
Figure 1. Injection site affects ESNP dispersal in the hippocampus. (A) Schematic of 17 representative transplants shows both the needle
track (arrows) and placement of ESNPs 4 weeks following surgery in either the hippocampal fissure (HF, green arrows) or the upper blade of the DG
(DG, blue arrows). (B) ESNPs (green) injected into the hippocampus disperse through the HF and persist at 4 weeks following transplantation (C). (D)
When the injection site is closer to the DG, ESNPs are dispersed along the upper blade, where they persist at 4 weeks (E) and can send processes
contacting cells in the CA3 pyramidal layer (F). Cell nuclei are counterstained blue with Hoechst.
doi:10.1371/journal.pone.0015856.g001
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is a candidate molecule for regulating ESNP migration in the adult
hippocampus.
CXCL12 is Upregulated Following KA-Induced Seizures
We next asked whether seizures impacted the expression of
CXCL12 in the hippocampus. At the time of injection of ESNPs
into the DG, post-seizure expression of CXCL12 was elevated in
the DG and CA3, compared to control mice that did not
experience prior seizures, based upon immunohistochemical
analysis (Figure 4A, B). The most pronounced increase in
CXCL12 expression over basal levels was observed in the SGZ
and hilus of the DG (arrows, Figure 4D). To further investigate the
role of seizures in induction of CXCL12, levels of mRNA were
measured after KA-induced seizures. CXCL12 mRNA levels from
whole hippocampal lysates increased approximately 3-fold within
one day following KA injection and remained elevated 7 days later
(Figure 4E). These data demonstrate that seizures augment
CXCL12 expression in the DG.
AMD3100 Inhibits the Migration of Transplanted ESNPs
Based on our in vitro migration data and the expression of
CXCL12 in the DG, we hypothesized that CXCL12 guides the
migration of ESNPs through the degenerating upper blade of the
DG following transplantation. To test this hypothesis, we blocked
CXCR4 activity by infusing mice with AMD3100 via osmotic
minipumps implanted subcutaneously. Previous studies showed
that AMD3100 crosses the blood-brain barrier and exerts
physiological effects in the CNS [41].
ESNPs were transplanted either into mice with no prior seizure
experience (PBS) or mice that had received systemic KA injection
(SE), and a subset of these mice also received infusions of
AMD3100 (SE+AMD). In both the PBS and SE groups not
treated with AMD3100, reconstructions of cells grafted to the DG
showed a large posterior extension along the upper blade in the
septotemporal axis. There was a slight increase in this extension in
the SE group versus the PBS group. These data suggest that the
upregulation of CXCL12 by seizures (Figure 4) in the adult
hippocampus can increase migration of transplanted ESNPs along
Figure 2. ESNPs disperse along the anterior-posterior axis of the DG upper blade following transplantation. (A) Horizontal and lateral
reconstructions of representative transplants to the upper blade show the initial dispersion of ESNPs (green) from the injection site (*). The graft then
extends along the upper blade in the posterior direction over the course of a week. (B) Quantification of the graft extent along the septotemporal axis
shows that the maximum distance is reached by one week following transplantation. (C) Analysis of graft distribution shows that transplanted cells
initially cluster close to the injection site and then are more evenly distributed as the graft extends to the posterior hippocampus over the course of 7
days. * and ** denote p values less than 0.05 and 0.01 by Student’s t-test, respectively.
doi:10.1371/journal.pone.0015856.g002
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extent of the grafts was truncated along this axis (Figure 5A). In
addition, a significant portion of the grafts in the SE+AMD group
clustered near the injection site when compared with controls
(58.7% vs. 37.2%, Figure 5B). The AMD3100-induced reduction
in migration is consistent with a role for CXCL12 in vivo
(Figure 5D).
An alternative explanation of the data could be that AMD3100
infusion led to truncation of the total graft volume due to toxic
effects on the transplanted cells (Figure 5E). To evaluate this, we
next assessed whether treatment with AMD3100 affected ESNP
survival in culture. In vitro treatment with AMD3100 did not
increase apoptosis nor did it alter the extent of differentiation
(Figure S4). In addition, the average cell density of the transplants
in the SE+AMD group was significantly higher than controls
(p,0.01, Figure 5F), suggesting the cells remain clustered around
the injection site with AMD treatment, unable to migrate.
Consistent with this hypothesis, the largest difference in density
between the SE and AMD3100-treated groups was in the sections
closest to the injection site (Figure 5C). The observations that
Figure 3. CXCL12 induces migration through the CXCR4 pathway in ESNPs. ESNPs expressing nestin (green, A) and the immature neural
marker b-III tubulin (B, green) co-labeled with the CXCL12 receptor, CXCR4 (A and B, red). (C) In an in vitro trans-well migration assay, CXCL12 induced
migration across the membrane in a dose-dependent manner (p,0.01 ANOVA). (D) Expression of CXCL12 mRNA as well as mRNA for both CXCL12
receptors, CXCR4 and CXCR7, was present in ESCs (ES), E12.5 whole brain lysates (WB) and transplanted ESNPs (TX). (E) In an in vitro trans-well
migration assay, blockade of the CXCR4 receptor with a small pharmacological inhibitor, AMD3100, was sufficient to eliminate CXCL12-induced
migration (p,0.01, ANOVA). * denotes p values ,0.05 by Student’s t-test.
doi:10.1371/journal.pone.0015856.g003
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that ESNPs are more densely clustered near the injection site, are
consistent with the interpretation that AMD3100 infusion inhibits
ESNP migration in the DG, implicating a role for CXCL12 as a
chemoattractant for ESNP migration.
ESNPs Differentiate in the Upper Blade of the DG
Seizure activity leads to dynamic changes in the hippocampus,
resulting in a transient increase in neurogenesis in the DG [32].
These observationssuggestthat seizuresmight affectESNP cell fates
after transplantation. We first examined the temporal pattern of
differentiation of ESNPs transplantedto the DG inanimals that had
experienced prior seizures. Within one week following transplan-
tation into the DG, a majority of the transplanted ESNPs showed
loss of nestin expression, suggesting that they had differentiated
(Figure 6A, G). By 4 weeks after transplantation, little nestin
expression was observed in the grafted cells (Figure 6B). Concur-
rently, transplanted cells showed increased expression of double-
cortin (DCX), a marker for migrating neuroblasts, peaking 3 to 7
days following transplantation (Figure 6C, G). As observed for
nestin, DCX expression was downregulated with longer survival
periods of 4 weeks (Figure 6D), suggesting that ESNPs differentiate
in the adult DG and upregulate DCX, consistent with a migratory
phenotype (Figure 6G). Further differentiation of ESNPs towards
DGNs coincided with expression of Prox1 (Figure 6E), a marker of
endogenous neural precursors of the SGZ and of mature DGNs in
theGCL ofthe DG[42]. Prox1 expression inthe ESNP-derived cell
population increased between 1 and 4 weeks (Figure 6H).
Concomitant with Prox1 expression, the mature pan-neural marker
NeuN begins to be expressed at 1 week after transplantation and
levels increased up to 4 weeks following transplantation (Figure 6F,
H). In addition, a portion of the grafted cells sent projections toward
the pyramidal cells of CA3, (Figure 1E, F). Taken together, these
data suggest that in mice subjected to SE, a high proportion of
ESNPs transplanted to the DG differentiate rapidly into migratory
neuroblasts, and subsequently give rise to DGNs.
Figure 4. CXCL12 expression increases in the DG following KA-induced seizures. Immunofluorescent staining revealed a low level of
CXCL12 expression in the hippocampus prior to seizures (red, A). Expression was markedly increased 7 days following KA-induced seizures (red, B).
Arrows denote examples of CXCL12-immunoreactive cells. (C, D) Confocal imaging of the boxed areas in A and B showed a dramatic increase of
CXCL12 staining of cells in the SGZ as well as the hilus of the DG and the CA3 pyramidal layer. (E) Quantitative RT-PCR analysis of whole hippocampal
lysates showed a 2.5 to 3.5-fold increase in CXCL12 message (three mice per time point, p,0.01 ANOVA).
doi:10.1371/journal.pone.0015856.g004
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PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15856Figure 5. AMD3100 blocks the migration of ESNPs along the upper blade of the DG. (A) Horizontal and lateral reconstructions of
representative grafts in the upper blade 4 weeks following transplantation to the DG revealed a truncated posterior extent of the grafts in mice with
prior seizure experience and minipumps infusion of AMD3100 (SE+AMD), as compared to mice that only received KA injections (SE). Additionally,
mice that did not experience seizures prior to transplantation (PBS) showed comparable graft migration in the posterior direction, compared to the
SE group. (B) The graft distribution in the SE+AMD group was less dispersed, and cells remained closer to the injection site compared with the
transplants in the SE group. (C) The density of grafted cells in the SE+AMD group was significantly greater near the injection site, compared with cell
densities in the SE group. Both the septotemporal extent (D) and average volume (E) of the grafts in both the PBS and SE groups were significantly
greater than that of the SE+AMD group. (F) Average cell density of the SE+AMD group was much greater in the SE+AMD groups than either the PBS
or SE groups. * and ** denote p values less than 0.05 and 0.01 by Student’s t-test, respectively.
doi:10.1371/journal.pone.0015856.g005
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the DG
Seizures upregulate a number of factors that increase endog-
enous neurogenesis in the DG [34,43]. While our data suggest that
elevated levels of CXCL12 following KA-induced seizures do not
alter the migration of transplanted cells, increased CXCL12 or
other seizure dependent changes may affect the differentiation of
transplanted cells. Therefore, we investigated whether prior
seizure experience affected the fates of transplanted ESNPs.
Expression of the NSC marker nestin in our ESNP grafts was not
Figure 6. ESNPs differentiate in the upper blade of the DG. ESNPs were transplanted into the upper blade of the DG and mice were sacrificed
immediately following transplantation, or 3, 7 (A, C, E) and 28 (B, D, F) days following transplantation. The NSC marker nestin (red, A, B) and the
migratory neuroblast marker doublecortin (DCX, red, C, D) showed reduced expression by 4 weeks following transplantation. (G) Quantification of
Nestin and DCX expression in transplanted cells revealed a decrease of the NSC marker Nestin following transplantation and a peak of DCX
expression at 3 days following transplantation. The dentate granule-specific marker Prox1 (red, E) and the pan-neural marker NeuN (red, F) showed
little to no expression initially (0 days), but expression increased up to 28 days following transplantation (H).
doi:10.1371/journal.pone.0015856.g006
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was an increase in the expression of the dentate-specific marker
Prox1 in the SE group, as compared to the no seizure control
group (Figure 7B). In addition, the percent of transplant-derived
neurons increased by as much as 40% in mice that had prior
seizure experience (Figure 7C). More transplanted cells expressed
NeuN throughout the graft area in the SE group than in the PBS
group (Figure 7D, E). In addition, grafted cells in the control group
expressed a higher level of the astrocyte specific protein glutamine
synthetase than either the SE or SE+AMD groups, suggesting that
without prior seizures, grafted ESNPs are more likely to
differentiate into glial cells than neurons (Figure S5).
Discussion
The findings of the present study show that ESNPs transplanted
into the hippocampus have a stereotypical pattern of dispersion
when they are transplanted into the HF or infragranular zone of
the DG, in each case likely following paths of least resistance
established by injection under pressure. In contrast, we observed
that ESNPs generally avoided other subfields of the hippocampus.
Within the confines of the DG, transplanted ESNPs migrated
within the first week along the upper blade toward the posterior
hippocampus, replacing lesioned cells in the GCL over an expanse
of 2 mm. Numerous studies have documented the extensive
migration of SVZ neural progenitors through the RMS into the
olfactory bulb [44,45]. Recent analysis shows that the chemokine
CXCL12 plays a critical role for NSC entry into the RMS [46].
Within the DG, newly born endogenous neurons migrate short
distances from the SGZ into the GCL, where they mature into
DGNs [47]. Future studies will determine whether endogenous
SGZ progenitors can migrate in an anterior-posterior manner
along the DG, in the presence or absence of a localized lesion.
Our findings suggest that transplanted ESNPs incorporate into
sites where endogenous DGNs undergo degeneration in the upper
blade of the dorsal hippocampus. Because granule cells in the
septal/dorsal hippocampus receive synaptic information from the
entorhinal cortex, and play a crucial role in spatial memory [48],
patients with intractable TLE may suffer significant memory losses
after ablation of an epileptic focus in the DG. Young DGNs may
be especially important for memory consolidation [49]. Migration
of ESNPs following transplantation to the upper blade may
require the death of the endogenous DGNs, as the migration of
transplanted ESNPs through the upper blade correlates with the
degeneration of the endogenous DGNs.
Targeting ESNPs to specific zones along the septotemporal
axis of the hippocampus could provide an effective therapeutic
strategy for hippocampal repair. Our studies suggest that at least
part of the mechanism for guiding new cells to their final
position in the granule cell layer is the expression of CXCL12,
as ESNPs show a directional migration toward a source of this
chemokine in vitro, and their migration is truncated in vivo after
infusion with AMD3100, an inhibitor of CXCR4. Our data
demonstrate that this chemokine could originate from sources in
the hippocampus as well as the transplant population. Previous
studies have shown increases in inflammatory cytokines
following trauma that may contribute to the migration of
transplanted ESNPs [50]. Additionally, CXCL12 upregulation
following seizures may promote a slightly more robust migratory
event. Alternatively, seizures may exacerbate the damage from
Figure 7. Prior seizure experience increases neuronal differentiation of transplanted ESNPs in the DG. (A) No significant difference is
observed in the NSC marker nestin between either the PBS or SE groups. (B) An increase in the dentate specific marker Prox1 is also observed in cells
injected into mice with prior seizure experience. (C) Quantification of NeuN expression shows that prior seizure experience leads to a 40% increase in
NeuN expressing cells as compared to PBS controls. More grafted cells (green, arrowheads) express the pan-neuronal marker NeuN when
transplanted to the DG of mice that had experienced KA-induced seizures (E) than mice that had only received PBS injections (D). * and ** denote p
values less than 0.05 and 0.01 by Student’s t-test, respectively.
doi:10.1371/journal.pone.0015856.g007
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extensively.
Differentiation of ESNPs
We previously reported that subsets of ESNPs grafted to the
neurogenic region of the DG expressed Prox1, a granule neuron-
specific marker; however, when transplanted to the fimbria, a fiber
tract of the hippocampus, ESNPs preferentially differentiated into
oligodendrocytes [2]. Others have reported that neural progeni-
tors from adult or fetal tissue can also differentiate into neurons
when transplanted into the DG [51,52]. The SGZ stem cell niche
is tightly controlled by growth factors, such as sonic hedgehog,
VEGF and BDNF [43,53,54,55]. Under homeostatic conditions,
radial NSCs slowly proliferate and give rise to a faster proliferating
intermediate astrocyte-like stem cell in the SGZ [56]. As these cells
differentiate and migrate into the GCL, they express the migrating
neuroblast marker DCX as well as Prox1 [57]. Once these
neuroblasts reach their final position in the GCL, they extend a
dendritic arbor to the molecular layer and mossy fiber axons to
targets in CA3.
Progression from astrocyte-like NSC to DGN during adult
neurogenesis in the SGZ takes approximately one month [58]. In
the transplanted population, we observed rapid differentiation,
with a decline in nestin-expressing ESNPs within 1 week following
injection into the DG. In addition, DCX labeled a majority of
grafted cells by 3 days following transplantation, and then was
rarely detected after 4 weeks. This pattern of expression is
consistent with our migration data that demonstrate little posterior
movement within three days, but significant migration at one week
(Figure 3B). While it takes weeks under normal conditions for
newborn cells to mature into neurons in the adult DG [59],
approximately 10% of our grafted cells express the pan-neural
marker NeuN by 7 days following transplantation. This may be
due to the presence of more differentiated cells in the transplant
population, of which 16% express DCX. Alternatively, the post
seizure environment may induce more rapid differentiation of
both endogenous and ESC-derived progenitors.
In addition to accelerated neurogenesis, KA-induced seizures
altered the differentiation of ESNPs by promoting neuronal, rather
than glial, phenotypes. It is well established that rodent models of
TLE initially augment the rate of neurogenesis in the hippocam-
pus [32,60]. Many factors that promote the proliferation and
neuronal differentiation of SGZ stem cells are upregulated
following seizures. For example, BDNF injection alone is sufficient
to increase hippocampal neurogenesis [61]. In addition, seizures
can lead to microglial invasion and reactive gliosis, a potential
source for inflammatory cytokines [62]. Moreover, microglia may
protect NSCs from factors such as interferon gamma, that
suppress proliferation [63]. Recent studies have shown that
microglial invasion coincides with the increased expression of
cytokines in the DG following pilocarpine administration [64].
Our data corroborate earlier studies demonstrating that CXCL12
expression is increased following status epilepticus, but this
increase may be transient without spontaneous recurrent seizures.
In addition to seizure-induced changes in the hippocampal
environment, the degeneration of the upper blade following fluid
injection may increase the expression of factors that may influence
the fates of transplanted cells. While previous studies have not
documented increases in neurogenesis following dorsal hippocam-
pal lesions in the DG, transient increases in NSC proliferation are
observed in similar models of traumatic brain injury [65]. These
factors may collectively instruct ESNP differentiation into neurons
following transplantation to the DG.
Here, we show that ESNPs transplanted into the DG of the
hippocampus migrate along the upper blade. This migration is
mediated by the chemokine CXCL12, which is upregulated by
seizures. Furthermore, prior seizure experience promotes the differen-
tiation of transplanted cells into neurons. These findings have
implications for cell-based therapies in patients with intractable severe
seizures. Our results show that ESNPS are recruited to sites of damage.
Improper migration of transplanted cells could lead to ineffective
treatment or exacerbation of the disease phenotype. Therefore,
identifying key regulatory molecules for guiding migration of
transplanted cells will lead to more effective stem cell-based therapies
for neurodegenerative diseases, traumatic brain injury, and epilepsy.
Supporting Information
Figure S1 Characterization of ESNPs. Prior to transplantation,
ESNPs expressed robust nestin (red, A) and b-III tubulin staining
(red, B). (C) Quantification of immunofluorescent staining showed
that over 92% of transplanted ESNPs expressed nestin, with fewer
than 10% of the cells adopting neural fates, as shown by
expression of the immature neuronal marker b-III tubulin. (D)
RT-PCR analysis of YC5 embryonic stem cells (ES), E12.5 whole
brain lysates (WB) and transplanted ESNPs (TX) showed that
transplanted cells expressed markers for early NSCs (Sox1, Otx2),
ventral NSCs (Mash1, Nkx2.1) and pluripotency (Oct4), albeit at a
lower levels than ES cells. Primer sequences were as follows: Oct4
59- CTCGAACCACATCCTTCTCT -39 and 59- GGCG-
TTCTCTTTGGAAAGGTGTTC -39, Sox1: 59- AATCC-
CCTCTCAGACGGTG -39 and 59- TTGATGCATTTTG-
GGGGTAT -39, Otx2: 59- AGGAGCTGAGTCGCCACCTC -
39 and 59- GTAGCCCAGGGAGGGATGCA -39, Emx1: 59-
AGCGACGTTCCCCAGGACGGGCTGC -39 and 59- CTG-
AGGTCACTTGGTC -39, Pax7: 59 – CCGTGTTTCTC-
ATGGTTGTG -39 and 59- GAGCACTCGGCTAATCGAAC -
39, Mash1: 59- CGACAGGACGCCCGCCTGAAAG -39 and 59-
CTCGTCCTCTCCGGAACTGATG -39, Nkx2.1 59- AAC-
AGCGGCCATGCAGCAGCAC -39 and 59- CCATGTTC-
TTGCTCACGTCC -39, and Lhx6: 59- CGACGACATCCAC-
TACTCTCCGT -39 and 59- CAAGCTGAATTCGCCAT-
TGCTCC -39.
(TIF)
Figure S2 Endogenous DGNs degenerated within one week
following ESNP transplantation to the upper blade. (A,B)
Immediately following transplantation, NeuN+ neurons (red) in
the upper blade were intact, and transplanted ESNPs (green)
were clustered at the site of injection. (C,D) Within three days,
significant degeneration of endogenous neurons in the upper
blade was observed. (E,F) By one week, transplanted ESNPs
began to express NeuN (arrows, inset) and degeneration of the
upper blade continued. (G,H) By four weeks following trans-
plantation, more engrafted cells were expressing NeuN (arrows,
inset), and no more degeneration was observed. Nuclei are
counterstained by Hoechst (blue).
(TIF)
Figure S3 CXCL12 did not alter the proliferation or differen-
tiation of YC5 ESNPs. YC5 ESNPs were treated with 200 ng/mL
CXCL12 for three days, fixed and stained for markers of
proliferation and differentiation. (A) Quantification of phospho-
histone H3 revealed no significant difference between CXCL12
treated and untreated ESNPs. (B) Quantification showed similar
levels of nestin and b–III tubulin staining after treatment with
CXCL12 as compared to controls.
(TIF)
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of ESNPs. YC5 ESNPs were treated with 5 mg/mL AMD3100 for
three days, fixed and stained. (A) Quantification of nestin and b-III
tubulin staining showed no significant difference between
AMD3100 treated and untreated cultures. (B) Levels of activated
caspase 3, a marker for apoptosis, were similar between the two
groups, and there were no differences between the NSC and
immature neural populations as well.
(TIF)
Figure S5 Prior seizure experience leads to lower expression of
the astrocyte marker glutamine synthetase. Glutamine synthetase
(red, A-D) is expressed mainly by astrocytes. ESNPs (green, A-D)
transplanted into mice with no prior seizure experience (PBS, A-B)
show greater fluorescence intensity for glutamine synthetase than
ESNPs grafted into mice with prior seizure experience (SE, C-D).
(E) Normalizing fluorescence intensity of glutamine synthetase in
ESNP grafts (yellow) to the PBS group, both the SE and the
AMD3100 treated group (SE+AMD) had significantly lower
fluorescence intensity. (F) As seizures are known to induce the
activation and proliferation of astrocytes, the fluorescence intensity
of glutamine synthetase in graft and non-graft areas were
compared. Grafts of ESNPs showed greater average intensity of
glutamine synthetase staining than the area surrounding the graft,
and this ratio was significantly higher than both the SE and the
SE+AMD groups.
(TIF)
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